華微電子(600360.SH)2019年度淨利潤預降39.63%到68.87%
格隆匯1月22日丨華微電子(600360.SH)公佈,預計2019年年度實現歸屬於上市公司股東的淨利潤與上年同期相比,將減少4200.66萬元到7300.66萬元,同比減少39.63%到68.87%。
歸屬於上市公司股東的扣除非經常性損益的淨利潤與上年同期相比,預計減少3971.19萬元到7071.19萬元,同比減少41.20%到73.36%。
報告期內,主要由於市場競爭加劇,公司應對外部市場形勢,為爭取市場份額,採取了銷售價格及銷售產品結構調整策略,產品獲利能力降低。另外,受海外市場經濟影響,海外訂單減少。綜上述,導致歸屬於上市公司股東的淨利潤較上年同期減少。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.